PharVision Advisers’s Healthpeak Properties DOC Stock Holding History

PharVision Advisers’s Portfolio DOC Stock Details DOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,429	Closed	-$248K	–	258
2025 Q4	$248K	Buy	+15,429	New	+$272K	0.13%	394

Other funds holding DOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PharVision Advisers's DOC Position: Q1 2026 in Review

PharVision Advisers sold out of Healthpeak Properties (DOC) in Q1 2026, closing a stake of 15,429 shares — an estimated $248K sold.

PharVision Advisers first reported a position in DOC in Q4 2025 and held it in 1 quarter. The position peaked at $248K in Q4 2025. 761 funds tracked by Wall St. Rank hold DOC as of Q1 2026.

PharVision Advisers reported no remaining Healthpeak Properties position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 15,429 Healthpeak Properties shares in Q1 2026, an estimated $248K.
PharVision Advisers first reported a position in Healthpeak Properties in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Healthpeak Properties position peaked at $248K in Q4 2025.
761 funds tracked by Wall St. Rank held Healthpeak Properties as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.